In 2023, the market size for Penicillins and Streptomycins in dosage in Italy stood at an estimated $600 million. From 2024 to 2028, the forecasted data shows a consistent decline, with the value dropping from $572.55 million to $477.62 million, indicating a downward trend. The year-on-year percentage variations reflect a decrease of around 4.2% from 2024 to 2025, 4.4% from 2025 to 2026, 4.5% from 2026 to 2027, and 4.7% from 2027 to 2028. The 5-year CAGR stands at approximately -4.3%.
Future trends to watch for include:
- Potential shifts in healthcare policies affecting drug sales.
- Advancements in alternative antibiotic treatments.
- Market consolidation impacts and pricing pressures.
